<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Investing Insights for Charles River Laboratories International Employees: The Pros and Cons of Dollar-Cost Averaging vs. Lump-Sum Contributions

image-table

Healthcare Provider Update: Healthcare Provider for Charles River Laboratories International Charles River Laboratories International, Inc. is primarily known for providing various preclinical and clinical laboratory services to the pharmaceutical, medical device, and biotechnology industries. Their healthcare offerings include specialized services such as toxicology testing, bioanalysis, and laboratory research, but they do not act as a traditional healthcare insurance provider or offer direct healthcare services. Potential Healthcare Cost Increases in 2026 In 2026, significant premium increases are anticipated for health insurance plans within the Affordable Care Act (ACA) marketplace, driven by escalating medical costs and the possible expiration of enhanced federal subsidies. Some states may see hikes exceeding 60%, particularly affecting low and middle-income families reliant on these plans. With reports indicating that over 90% of marketplace enrollees could face premium raises of 75% or more, the landscape for healthcare affordability will become increasingly challenging, prompting consumers and companies alike to reassess their healthcare strategies and financial planning. Click here to learn more

Table of Contents

The Value Series

4-Aug-24-2022-08-25-41-54-PM

Given the current elevated market volatility, we think now is a good time to revisit important value metrics in our four-part series. As an employee or retiree of Charles River Laboratories International, who likely has little market analysis experience, we understand that the valuation process can seem confusing. However, we are here to tell you that the valuation process does not have to be complex to be successful. Simple valuation techniques such as the price-to-book ratio are generally easy to use and have been proven to be effective if utilized correctly.  Investors are often looking for ways for their clients to beat the market. If you're one of those investors, you may want to consider the following strategy that has been implemented by the investment greats. Some value investors have historically beat the average annualized returns of the S&P 500, and many have successful track records spanning several decades to prove it. Charles River Laboratories International employees, it is important to be knowledgeable regarding tactics used by famous investors such as Warren Buffett, Benjamin Graham, David Dodd, Charlie Munger, Christopher Browne and Seth Klarman. The investment style implemented by these professionals focus on four metrics that characterize a value investment. These four metrics include the Price to Earnings Ratio, the Price to Cash Flow Ratio, High Dividend Yield and the Price to Book Ratio. These metrics, as you will see, are strong indicators of undervalued security. If undervalued security is brought back to fair value then we would see positive returns on that security.  For Charles River Laboratories International employees, it is possible to utilize these metrics to better position yourself in the market for heightened returns. We will examine the effect of investing based off of certain characteristics and how their investment returns are correlated. Today, I want to end the four-part TRG Value Series with the granddaddy of metrics, the Price-to-Book value ratio (P/B).

What is Book Value?

3-Aug-24-2022-08-25-40-12-PM

Book value is preferred by many value investors to cash flow and earnings metrics because it is more stable year-to-year whereas cash flow and earnings can vary greatly. This is an important property for those at Charles River Laboratories International to look out for due to the following reason: When a business at a cyclical trough with diminished cash flow and earnings might look expensive on the basis of price-to-cash flow or price-to-earnings, that same business may appear cheap on the basis of price-to-book value. This is because book value won’t fall much or at all in a downturn, and vice versa. Thus, the argument goes, the price-to-book value gives a more reliable picture of a company’s usual business performance, which Charles River Laboratories International employees can use to elevate their investment decisions and investment performance. Benjamin Graham popularized the indicator in his books “Security Analysis” and “The Intelligent Investor”. Nobel Prize winner Eugene Fama and his research partner Kenneth French used the ratio in their three- and five-factor models to describe stock returns. Professor Joseph Piotroski uses the ratio as the only valuation measure in his F-Score methodology.

Testing

7-Aug-24-2022-08-25-42-42-PM

We understand the importance of data driven research for Charles River Laboratories International employees and retirees. Set out below are the results of two Fama and French backtests of the book value-to-market equity (the inverse of the PB ratio) data from 1926 to 2013. As of December 2013, there were 3,175 firms in the sample (Carlisle-PB, P2). The value decile contained the 459 stocks with the highest earnings yield, and the glamour decile contained the 404 stocks with the lowest earnings yield.

 

 

The average size of the glamour stocks is $7.48 billion and the value stocks are $2.54 billion. (Note that the average is heavily skewed by the biggest companies. For context, the 3,175th company has a market capitalization today of $404 million, which is smaller than the average, but still investable for most investors). Portfolios are formed on June 30 and rebalanced annually. When accounting for this backtest, Charles River Laboratories International employees may recognize how two portfolios are weighted by market capitalization, which means that bigger firms contribute more to the performance of the portfolio, and smaller firms contribute less. Here, we can see that the value decile has comprehensively outperformed the glamour decile, returning 12.6 percent compounded (17.7 percent in the average year) over the full period versus 8.6 percent for the glamour decile (10.9 percent in the average year) (Carlisle-PB, P3).

 

These returns are considerably lower than the returns found for the price-to-earnings and cash-flow ratios discussed earlier. Despite the irregularity, Charles River Laboratories International employees must be aware that the earnings and cash flow back tests ran back to only 1951, and the book value return data begins in 1926. The difference is due to the 1929 crash, which had an oversized impact on returns. The impact of the crash is visible on the chart; it took twenty years for the value decile to fully recover. Charles River Laboratories International employees must also note how something similar has happened to the glamour decile since 2000; it hasn’t grown in 13 years. To make a comparison possible of the book value’s performance to the performance of earnings and cash flow over the same period, I also measured the returns beginning in 1951. Since 1951, the low P/B value decile has generated a compound annual growth rate (CAGR) of 15.0 percent and an average annual return (AAR) of 17.9 percent. Over the same period, the glamour decile returned a CAGR of 9.6 percent and an AAR of 12.6 percent (Carlisle-PB, P5). These returns are approximately the same as the returns generated by the low P/CF and P/E studies over the same period.

 

 

In their study, they found that the quintile of the lowest P/E stocks significantly outperformed the high P/E quintile. The portfolio containing the lowest P/E stock returned 11.61% annualized compared to 4.83% for the highest P/E portfolio and 7.55% for the used universe of stocks. The graph below shows how the cumulative returns compare (it’s not even close). Charles River Laboratories International employees can utilize this information to avoid investing in underperforming assets and better predict economic trends that translate into higher ROI.

Articles you may find interesting:

Loading...

Weighting

2-Aug-24-2022-08-25-38-50-PM

It is important for employees and retirees of Charles River Laboratories International to understand how market capitalization-weighted returns are useful for demonstrating that the outperformance of value over glamour is not due to the value portfolios containing smaller stocks. Unless you’re running an index (or hugging an index), they’re not really meaningful. The easiest portfolio weighting scheme is to simply equally weight each position. (If we’re prepared to put up with a little extra volatility for a little extra return, we can also Kelly weight our best ideas). Kelly Weighting is determined by the Kelly Criterion which is a formula used to determine what percentage of their capital should be used in each trade to maximize long-term growth. There are two key components to the formula (Kelly % = W- [(1 - W) / R]): the winning probability factor (W) and the win/loss ratio (R). The winning probability is the probability a trade will have a positive return. The win/loss ratio is equal to the total positive trade amounts divided by the total negative trading amounts. The result of the formula will tell investors what percentage of their total capital they should apply to each investment. By utilizing the Kelly Weighting, investors employed or retiring from Charles River Laboratories International can have a better grasp of their exposure to each individual asset in their portfolio and make informed decisions regarding their asset allocation.

 

Charles River Laboratories International employees should also account for the equal weight return statistics for book value.  In the equal weight backtest, the value generated a 20.2 percent compounded return (27.3 percent on average), beating out glamour’s 6.3 percent compounded return (10.4 percent on average) (Carlisle-PB, P10). Since 1951 the equally weighted P/B value decile has generated a compound annual growth rate (CAGR) of 20.0 percent and an average annual return (AAR) of 25.4 percent (Carlisle-PB, P11).

 

 

 

 

Over the same period, the glamour decile returned a CAGR of 6.4 percent and an AAR of 10.8 percent. These returns are close to the same as the returns generated by the low P/CF and P/E studies over the same period. When accounting for this information, Charles River Laboratories International employees must recognize that the value portfolios outperformed because they bought more book value per dollar invested than the glamour portfolios: 4.57x on average versus 0.25x in the glamour portfolios (Carlisle-PB, P12). In the equal-weight portfolios, value has significantly outperformed glamour since 1999, beating it by an extraordinary 15.9 percent compounded, and 16.1 percent in the average year (Carlisle-PB, P13).

The Brandes Research Institute

5-Aug-24-2022-08-25-37-02-PM

Because we understand just how important data-driven solutions are for our Charles River Laboratories International employees and retirees, we have provided another study, which discusses the P/CF ratio. In a Brandes Research Institute study, Exhibit 6 below illustrates the global all-cap findings across three price metrics.

 

 

 

 

The results confirmed a consistent value premium across all metrics. We will focus on the P/CF ratio and the outperformance in the decile 10 value stocks. The smallest outperformance between decile 1 glamour stocks and decile 10 value stocks can be observed with the P/B measurement, where the average outperformance was 7.1% (Brandes, p. 8).

About The Retirement Group    

9-Aug-24-2022-08-25-41-38-PM

The Retirement Group is a nation-wide group of financial advisors who work together as a team.

 

We focus entirely on retirement planning and the design of retirement portfolios for transitioning corporate employees. Each representative of the group has been hand selected by The Retirement Group in select cities of the United States. Each advisor was selected based on their pension expertise, experience in financial planning, and portfolio construction knowledge.

TRG takes a teamwork approach in providing the best possible solutions for our clients’ concerns. The Team has a conservative investment philosophy and diversifies client portfolios with laddered bonds, CDs, mutual funds, ETFs, Annuities, Stocks and other investments to help achieve their goals. The team addresses Retirement, Pension, Tax, Asset Allocation, Estate, and Elder Care issues. This document utilizes various research tools and techniques. A variety of assumptions and judgmental elements are inevitably inherent in any attempt to estimate future results and, consequently, such results should be viewed as tentative estimations. Changes in the law, investment climate, interest rates, and personal circumstances will have profound effects on both the accuracy of our estimations and the suitability of our recommendations. The need for ongoing sensitivity to change and for constant re-examination and alteration of the plan is thus apparent.

Therefore, we encourage you to have your plan updated a few months before your potential retirement date as well as an annual review. It should be emphasized that neither The Retirement Group, LLC nor any of its employees can engage in the practice of law or accounting and that nothing in this document should be taken as an effort to do so. We look forward to working with tax and/or legal professionals you may select to discuss the relevant ramifications of our recommendations.

Throughout your retirement years we will continue to update you on issues affecting your retirement through our complimentary and proprietary newsletters, workshops and regular updates. You may always reach us at (800) 900-5867.

Sources

6-Aug-24-2022-08-25-38-46-PM
  1. What to do with an Early Retirement Ebook

  2. Social Security Ebook

  3. Lump Sum vs. Annuity Ebook

  4. 401(k) Rollover Strategies Ebook

  5. Closing the Retirement Gap Ebook

  6. Brandes Institute, The. “Value vs. Glamour: A Long-Term Worldwide Perspective”. 2014. < https://www.brandes.com/docs/default-source/brandes-institute/value-vs-glamour-worldwide-perspective>. 

  7.  Carlisle, Tobias. “Investing Using the Price-to-Earnings Ratio and Earnings Yield (Backtests 1951 to 2013)”. May 26, 2014. <http://greenbackd.com/2014/05/26/price-to-earnings-ratio-backtest-1951-to-2013/>.

  8. Causeway Capital. “The Compelling Case for Value Stocks”. 2018 https://www.causewaycap.com/wp-content/uploads/2018/02/201802-TheCompellingCaseforValue-1.pdf

  9. Research Affiliates. “To Win with ‘Smart Beta’, Ask if the Price is Right” September 7, 2016 < https://seekingalpha.com/article/4004564-win-smart-beta-ask-price-right>

  10. Tweedy Browne Company LLC. “What Has Worked in Investing: Studies of Investment Approaches and Characteristics Associated with Exceptional Returns.” 1992. <http://www.tweedy.com/resources/library_docs/papers/WhatHasWorkedFundVersionWeb.pdf>.

  11. Yuan, Vera. Guru Focus. “Earnings, Free Cash Flow, Book Value? Which Parameters Are Stock Prices Most Correlated To?”. August 2, 2013. < http://www.gurufocus.com/news/225255/earnings-free-cash-flow-book-value-which-parameters-are-stock-prices-most-correlated-to->.

  12. Fama and French Backtesting http://mba.tuck.dartmouth.edu/pages/faculty/ken.french/data_library.html

What type of retirement savings plan does Charles River Laboratories International offer?

Charles River Laboratories International offers a 401(k) retirement savings plan to its employees.

Does Charles River Laboratories International match employee contributions to the 401(k) plan?

Yes, Charles River Laboratories International provides a matching contribution to employee 401(k) contributions, subject to certain limits.

What is the eligibility requirement to participate in the 401(k) plan at Charles River Laboratories International?

Employees of Charles River Laboratories International are generally eligible to participate in the 401(k) plan after completing a specified period of service.

How can employees of Charles River Laboratories International enroll in the 401(k) plan?

Employees can enroll in the 401(k) plan through the company’s benefits portal or by contacting the HR department at Charles River Laboratories International.

What investment options are available in the 401(k) plan at Charles River Laboratories International?

Charles River Laboratories International offers a variety of investment options in its 401(k) plan, including mutual funds, target-date funds, and other investment vehicles.

Can employees of Charles River Laboratories International take loans against their 401(k) savings?

Yes, Charles River Laboratories International allows employees to take loans against their 401(k) savings, subject to the plan's rules and regulations.

What is the vesting schedule for employer contributions in the 401(k) plan at Charles River Laboratories International?

The vesting schedule for employer contributions at Charles River Laboratories International may vary, but typically follows a graded vesting schedule over several years.

How often can employees of Charles River Laboratories International change their 401(k) contributions?

Employees can change their 401(k) contribution amounts at any time, subject to the plan's guidelines set by Charles River Laboratories International.

Are there any fees associated with the 401(k) plan at Charles River Laboratories International?

Yes, there may be administrative fees associated with the 401(k) plan at Charles River Laboratories International, which are disclosed in the plan documents.

What resources does Charles River Laboratories International provide to help employees manage their 401(k) investments?

Charles River Laboratories International provides educational resources, access to financial advisors, and online tools to help employees manage their 401(k) investments.

With the current political climate we are in it is important to keep up with current news and remain knowledgeable about your benefits.
Update: In 2024, Charles River Laboratories International has announced a significant overhaul of its 401(k) plan, which includes increasing the company match percentage and introducing a new vesting schedule. This change is aimed at improving employee retention and competitive positioning. The update is crucial in the current economic environment where employees are seeking better retirement benefits amid economic uncertainty.
Restructuring Layoffs: Charles River Laboratories announced a workforce reduction in early 2024. The company is consolidating its facilities and focusing on higher-margin services, resulting in layoffs primarily affecting administrative and support roles. This restructuring is part of their broader strategy to streamline operations and reduce costs amidst economic uncertainty.
Charles River Laboratories International Stock Options and RSUs 2022 Stock Options: Charles River Laboratories International granted stock options primarily to executives and senior management. These options typically had a vesting period of 4 years with annual vesting in 25% increments. RSUs: RSUs were awarded to a broader employee base, including senior executives and key employees. These units generally vested over a period of 3 years with a performance component tied to company goals. Availability: Stock options and RSUs were part of the company's broader compensation package to attract and retain top talent, with specific allocations based on role and performance. 2023 Stock Options: Charles River Laboratories International continued to offer stock options, mainly to higher-level executives and employees in strategic roles. The options typically had a 4-year vesting schedule with performance criteria. RSUs: In 2023, Charles River Laboratories International expanded its RSU program to include mid-level management. The vesting schedule remained similar, with a 3-year timeline and performance metrics. Availability: Both stock options and RSUs were used to incentivize employees and align their interests with company performance, with allocation levels varying by position and individual performance. 2024 Stock Options: For 2024, Charles River Laboratories International maintained its stock option program, focusing on key positions and high performers. The vesting schedule continued to be spread over 4 years. RSUs: The RSU program for 2024 included adjustments to address market conditions and employee retention. The vesting period stayed at 3 years, with an increased emphasis on performance-based criteria. Availability: The stock options and RSUs were integral to the company’s compensation strategy, aimed at rewarding contributions and aligning employee interests with the company’s long-term goals.
Charles River Laboratories International offers a range of health benefits designed to support employee well-being. For the years 2022, 2023, and 2024, the company has implemented comprehensive healthcare coverage including medical, dental, and vision insurance. In 2023, Charles River Laboratories introduced a new Health Savings Account (HSA) option for employees, allowing for more flexible contributions and tax advantages. Additionally, the company provides an Employee Assistance Program (EAP) to support mental health and work-life balance. Recent updates also include enhanced telehealth services and expanded coverage for preventive care. In the current economic and political climate, Charles River Laboratories' healthcare offerings play a crucial role in attracting and retaining talent. As the investment landscape evolves, the company's commitment to comprehensive healthcare benefits helps mitigate employee concerns about medical costs and access to care. This focus on health benefits is particularly relevant amid ongoing discussions about healthcare policy reforms and economic fluctuations, which can impact both corporate budgets and employee well-being. As such, Charles River Laboratories' proactive approach to healthcare is an important factor in maintaining employee satisfaction and organizational stability.
New call-to-action

Additional Articles

Check Out Articles for Charles River Laboratories International employees

Loading...

For more information you can reach the plan administrator for Charles River Laboratories International at 251 Ballardvale St. Wilmington, MA 1887; or by calling them at 1-781-222-6000.

https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia https://www.marketwatch.com/ http://www.thelayoff.com/ http://www.sec.gov/ http://www.fidelity.com/ http://www.morningstar.com/ http://www.bloomberg.com/ https://www.thelayoff.com/ https://www.businessinsider.com/ https://www.reuters.com/ https://www.bloomberg.com/asia

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Charles River Laboratories International employees